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Objective: To evaluate and compare lipid profile level in oral submucous fibrosis (OSMF), oral leukoplakia 
(OL) and oral squamous cell carcinoma (OSCC) patients. Material and Methods: Thirty 
histopathologically diagnosed subjects each of OL, OSMF, OSCC were recruited along with 30 healthy 
controls. 5ml of venous blood is collected and estimated using standard diagnostic kits. Results: The mean 
of Total cholesterol level in controls was 219.03 mg%, in OSCC, OL and OSMF was 142.89 ± 10.21mg%, 
155.44 ± 17.63 mg% and 180.60 ± 13.25 mg%, respectively. The mean low-density lipid level in controls 
was 137.24 mg and in OSCC, OL and OSMF groups were 109.28 ± 2.16 mg%, 126.63 ± 0.85 mg% and 
119.15 ± 0.93 mg%, respectively. The mean of high-density lipid level in controls, OSCC, OL and OSMF 
was 42.87 ± 0.42 mg%, 36.50 ± 2.31 mg%, 21.13 ± 0.77 mg% and 28.37 ± 1.11mg%, respectively. The mean 
of very low density lipids level in controls, OSCC, OL and OSMF was 30.12 ± 1.51 mg%, 17.24 ± 0.80 
mg%, 22.25 ± 0.93 mg% and 25.89 ± 0.43 mg%, respectively. The mean triglyceride level in controls, 
OSCC, OL and OSMF was 118.80 ± 9.47 mg%, 91.2 ± 3.03 mg%, 105.05 ± 2.96 mg% and 106.19 ± 3.09 
mg%, respectively. Conclusion: Lipid profile levels could be early indicators of precancer and cancer. 
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Cancer is one of the leading causes of adult death worldwide. Oral cancer is a serious problem in many 
countries [1]. Along with pharyngeal malignancy, oral cancer is regarded as the ninth most common cause of 
malignancy worldwide and the third major cause of mortality in developing countries [2]. In India, oral cancer 
incidence is about 3 to 7 times more common compared to developed countries [3]. A high incidence of oral 
cancer (OC) is due to intense use of tobacco products. Therefore, cancer of the oral cavity is one of five leading 
sites of cancer in either sex [1]. A variety of tobacco habits are prevalent in India and they differ from region 
to region. The most widespread is the chewing of betel-quid with tobacco and this has been demonstrated as a 
major risk factor for cancers of the oral cavity. 
Among all oral malignancies, the most common malignancy contributing to about 90% is oral 
squamous cell carcinoma (OSCC) [1]. Not only OSCC but also the use of tobacco and arecanut can also lead to 
potentially malignant disorders [2]. Oral cavity cancer is currently the most frequent cause of cancer related 
deaths among Indian men, which is usually preceded by oral potentially malignant disorders like oral 
leukoplakia (OL) and/or oral submucous fibrosis (OSMF) [3]. Majority of the patients with potentially 
premalignant disorders are reported to be in 21-30 years of age group with a male to female ratio of 6.8:1 in 
India [1]. 
Early detection is the key for oral cancer control and one of the major reasons behind the high 
mortality rate of oral cancer is the delay in early diagnosis of the potentially malignant disorders, the 
precursors of oral cancer. Oxidative stress has been considered a significant factor in the pathogenesis of 
numerous diseases and the antioxidant levels play a significant role in the pathogenesis and treatment of 
malignancies [3,4]. There are various biochemical markers available for precancer and cancerous patients, out 
of which one such tumor marker is serum lipid profile. Lipids are major cell membrane components essential 
for various biological functions, including cell growth and normal and malignant tissue division. The possible 
influence of lipids in the pathogenesis of malignancies could be attributable to influence on the metabolism of 
malignant cells in terms of proliferation and incorporation in the membranes of neoplastic cells and lipids' 
function intercellular messengers or as mediators of the inflammatory reaction [5]. 
An association of serum lipids and lipoproteins with different cancers has been reported [6]. Even 
though significant changes in blood cholesterol have been noted, the question whether hypolipidemia is a 
predisposing factor or a result of cancer still remains unanswered. In the present study, we evaluated the 
different biochemical lipid parameters such as total cholesterol (TC), triglyceride (TGL), high-density lipid 
(HDL), low-density lipid (LDL), very low-density lipid (VLDL) lipoprotein levels in OSMF, OL and OSCC. 
We also correlated the lipid profile parameters studied in OL, OSMF, OSCC and control groups. 
 
Material and Methods 
Study Design and Ethical Clearance 
This study was planned and designed in the Department of Oral Medicine and Radiology, Hitkarini 
Dental College and Hospital, Jabalpur, Madhya Pradesh, India. This study was conducted over 2 years of 
duration and was approved by Institutional ethical committee (Protocol No. 18/032). 
 
Data Collection 
Thirty histopathologically diagnosed subjects each of OL, OSMF OSCC were recruited into the study 
and along with 30 healthy control subjects (without any oral habits), all recruited from patients attending 
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outpatient department, Hitkarini Dental College and Hospital, Jabalpur, Madhya Pradesh, India. OSCC 
subjects were recruited from Department of General surgery, Netaji Subhash Chandra Bose Medical College 
and Hospital, Jabalpur, India. The subject’s demographic data along with case history was recorded on a 
specially designed proforma. The study purpose and procedure were explained to the subjects and written 
informed consent was obtained. Patients with nephrotic syndrome, hyperthyroidism, diabetes mellitus, blood 
disorders, cardiovascular diseases were excluded from this study. 
 
Serum Sample Collection, Storage, and Handling 
About 5 ml of blood samples were collected from venous arm puncture from each of the subjects. The 
sample was then kept in a plain sterile glass bulb and allowed to clot for 30-60 min at room temperature, 
followed by centrifugation at 3000 RPM for 10-15 min. Ice or cold packs were used to transport the serum 
specimen to the laboratory. The serum lipid profile activity was determined on the same day. The 
concentration of lipid parameters was estimated by using respective diagnostic kits (Cholesterol kit, Transasia 
Biomedicals Ltd., Daman, India) and a semiautomatic analyzer (CHEM-5 Plus V2, ERBA Diagnostics 
Mannheim GmbH, Germany). The protocols for the estimation of TC, TGL and HDL were followed as per the 
instruction available in the kit literature. 
 
Statistical Analysis 
The data was analyzed using IBM-SPSS software, version 22.0 (IBM Corp., Armonk, NY, USA). 
Shapiro-Wilk test showed that age, total cholesterol, triglycerides, VLDL, HDL and LDL follow normal 
distribution hence parametric test one-way ANOVA (analysis of variance) followed by LSD post hoc test was 
used for comparison between different groups. Gender distribution in different groups (nominal data) was 
compared using Pearson’s chi-square test.  The significance was tested at 5% level. 
 
Results 
Age and gender-wise distribution of study groups are represented in Tables 1 and 2, respectively.  
 
Table 1. Age distribution in study groups. 
Groups Mean SD Age (Years) 
   Minimum Maximum 
Control 50.70 9.19 29.00 65.00 
Oral Squamous Cell Carcinoma 50.97 9.18 32.00 65.00 
Oral Leukoplakia 46.17 10.26 25.00 62.00 
Oral Submucous Fibrosis 51.73 8.82 35.00 65.00 
One-way ANOVA F= 2.169, p=0.095 
 
 
Table 2. Gender-wise distribution of study groups. 
 Gender  
Groups Male Female p-value 
 N % N %  
Control 27 90.0 3 10.0 0.147 
Oral Squamous Cell Carcinoma 26 86.7 4  13.3  
Oral Leukoplakia 30 100.0 0 0.0  
Oral Submucous Fibrosis 29 96.7 1 3.3  
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The mean TC level in the control control group was 219.03 mg% with a standard deviation of ± 11.00 
mg% in OSCC, OL and OSMF groups it was 142.89 ± 10.21 mg%, 155.44 ± 17.63 mg% and 180.60 ± 13.25 
mg% respectively (Table 3). 
 
Table 3. Total Cholesterol levels in study groups. 
Groups Total Cholesterol (mg%) 
Mean SD Minimum Maximum 
Control 219.03 11.00 204.00 246.00 
Oral Squamous Cell Carcinoma 142.89 10.21 130.60 160.00 
Oral Leukoplakia 155.44 17.63 106.00 195.00 
Oral Submucous Fibrosis 180.60 13.25 162.00 209.00 
One-way ANOVA F= 190.155, p<0.001 
LSD Post Hoc Test OSCC<OL<OSMF<Control 
 
The mean of total LDL level in control group was 137.24 ±2.50 mg%, in OSCC, OL and OSMF 
groups it was 109.28 ± 2.16 mg%, 126.63 ± 0.85 mg% and 119.15 ± 0.93 mg%, respectively (Table 4). 
 
Table 4. Total LDL levels in study groups. 
Groups LDL (mg%) 
Mean SD Minimum Maximum 
Control 137.24 2.50 131.80 139.75 
Oral Squamous Cell Carcinoma 109.28 2.16 107.60 114.80 
Oral Leukoplakia 126.63 0.85 125.40 127.90 
Oral Submucous Fibrosis 119.15 0.93 118.20 120.60 
One-way ANOVA F= 1338.234, p<0.001 
LSD Post Hoc Test OSCC< OSMF<OL<Control 
 
Similarly, the mean of total HDL level in control group was 42.87 ± 0.42 mg%, in OSCC, OL and 
OSMF groups it was 36.50 ± 2.31 mg%, 21.13 ± 0.77 mg% and 28.37 ± 1.11mg%, respectively (Table 5). 
 
Table 5. Total HDL levels in study groups. 
Groups HDL (mg%) 
Mean SD Minimum Maximum 
Control 42.87 0.42 42.50 43.60 
Oral Squamous Cell Carcinoma 36.50  2.31 35.23 48.20 
Oral Leukoplakia 21.13 0.77 20.31 22.35 
Oral Submucous Fibrosis 28.37 1.11 27.13 29.90 
One-way ANOVA F= 1472.431, p<0.001 
LSD Post Hoc Test Control>OSCC>OSMF>OL 
 
The mean of total VLDL level in control group was 30.12 ± 1.51 mg%, in OSCC, OL and OSMF 
groups it was 17.24 ± 0.80 mg%, 22.25 ± 0.93 mg% and 25.89 ± 0.43 mg%, respectively (Table 6). 
 
Table 6. Total VLDL levels in study groups. 
Groups VLDL (mg%) 
Mean SD Minimum Maximum 
Control 30.12 1.51 27.80 32.60 
Oral Squamous Cell Carcinoma 17.24 0.80 16.50 18.70 
Oral Leukoplakia 22.25 0.93 21.06 24.30 
 Pesqui. Bras. Odontopediatria Clín. Integr. 2021; 21:e0083 
 
5 
Oral Submucous Fibrosis 25.89 0.43 25.30 26.60 
One-way ANOVA F= 904.805, p<0.001 
LSD Post Hoc Test OSCC<OL<OSMF<Control 
 
The mean of total TGL level in control group was 118.80 ± 9.47 mg%, in OSCC, OL and OSMF 
groups it was 91.2 ± 3.03 mg%, 105.05 ± 2.96 mg%, 106.19 ± 3.09 mg%, respectively (Table 7). One-way 
ANOVA test showed a statistically significant difference among the study groups with respect to TC, LDL, 
HDL, VLDL, and TGL levels (p<0.001). 
 
Table 7. Total triglyceride levels in study groups. 
Groups Triglyceride (mg%) 
Mean SD Minimum Maximum 
Control 118.80 9.47 106.60 134.80 
Oral Squamous Cell Carcinoma 91.02 3.03 87.00 99.00 
Oral Leukoplakia 105.05 2.96 99.00 115.00 
Oral Submucous Fibrosis 106.19 3.09 101.00 118.00 
One-way ANOVA F= 131.992, p<0.001 
LSD Post Hoc Test OSCC<OL=OSMF<Control 
 
Discussion 
Head and neck cancer is one of the leading causes of morbidity and mortality with metastatic and 
invasive ability [7,8]. The habit of tobacco consumption is a known etiological factor. In malignant diseases, 
the blood cholesterol undergoes early and significant changes. Low levels of cholesterol in the proliferating 
tissues could be due to the process of carcinogenesis. However, the hypocholesterolemia that prevails is due to 
the cancer effects or is a cause for cancer occurrence yet to be answered [8]. 
Several explanations of the inverse associations between low serum cholesterol and cancer have been 
proposed and there may be a direct causal link between low cholesterol and cancer [9]. 
The reduced lipid profile may also be due to greater utilization of lipids for new membrane biogenesis, 
cells fulfill these requirements from circulation by synthesis through metabolism or from degradation of major 
lipoprotein fractions like HDL, LDL and VLDL [8]. 
There are three main competing hypotheses to explain this inverse association. First, lower 
cholesterol values, even before the manifestation or detection of cancer, may be a result of the cancer process; 
second, lower cholesterol values may precede the development of cancer, but the association with cancer is 
secondary, which indicates that cholesterol serves as a marker for some other causal variable or set of variables; 
third, lower cholesterol values may precede the development of cancer and may be causally associated with the 
occurrence of some forms of cancer [10]. 
Kark et al. [7] and Ray et al. [11] concluded that TC was found at significantly lower levels in oral 
cancer patients compared with controls of comparable age and sex distribution. Patel et al. [12] reported a 
decrease in plasma TC, HDL, VLDL, TGL levels in patients with oral malignancy as well as in patients with 
oral precancerous conditions as compared to the controls. The tobacco habituates showed lower plasma lipid 
levels than the non-habituates. Result of their study correlates with the result of the present study [12]. 
Similarly, Gupta and Gupta [13] observed a significant decrease in plasma total cholesterol, HDL, TC, and 
TGL in the patients with precancerous lesions and conditions, Singh et al. [14], reported a significant decrease 
in TC, HDLC and TGL in the oral cancer group. Kumar et al. [15] and Kanthem and Guttikonda [16] found 
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significantly decreased lipid levels in OSMF patients, Neerupakam et al. [17] noted a significant decrease in 
the total cholesterol and HDL in oral cancer subjects, which was similar to the results of our study. 
Lohe et al. [18] evaluated cholesterol levels in patients with precancer and oral carcinoma and a 
significant decrease in TC, HDL, VLDL and TGL was noted in later patients. Mehrotra et al. [19] noticed a 
significant decrease in plasma HDLC and Apo-A1 in patients with OSMF compared to the controls in 
accordance with the present study. In this study, authors found a significant increase in TC, LDL, VLDL and 
TGL levels, which were not similar with the present study [19]. 
 
Conclusion 
In the present study, the serum profiles were reduced in OSCC, OL, and OSMF subjects compared to 
healthy controls. Our study supports the fact that lipid profile levels can be used as a diagnostic parameter in 
detecting precancer and cancer early. The reduced lipid profile is of clinical beneficence to assess the prognosis 
of the patients and predict the survival rate in cases of OL, OSMF. Perhaps they could also be used to predict 
the malignant transformation. 
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